Anthracycline-related cardiotoxicity in childhood cancer survivors.
Curr Opin Cardiol. 2014 Jan;29(1):103-12
Authors: Lipshultz SE, Karnik R, Sambatakos P, Franco VI, Ross SW, Miller TL
Abstract PURPOSE OF REVIEW: Anthracyclines have markedly improved the survival rates of children with cancer. However, anthracycline-related cardiotoxicity is also well recognized and can compromise the long-term outcome in some patients.